It would be helpful if providers took a deeper dive into understanding why certain medications may not be effective or why treatment seems to plateau
"S Page 58 and 59: Boxall ABA, Ed., "Transformation pr Page 60 and 61: Braga O, Smythe GA, Schafer AI, and Page 62 and 63: Breitholtz M, Wollenberger L, and D Page 64 and 65: Brooks BW, Chambliss CK, Stanley JK Page 66 and 67: USEPA, EPA Grant Number: R829007, S Page 68 and 69: system." Environmental Toxicology a Page 70 and 71: Busetti F, Linge KL, Rodriguez C, a Page 72 and 73: and Environmental Safety 1999, 42(2 Page 74 and 75: California DTSC "Pharmaceutical Ind Page 76 and 77: Carolina State University, Raleigh, Page 78 and 79: Carballa M, Fink G, Omil F, Lema JM Page 80 and 81: 2085
Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial
Beyond combating oxidative stress, sulforaphane modulates immune responses
In more severe cases of hair loss, a doctor might prescribe oral minoxidil, which is generally absorbed better by the body but also typically comes with more side effects
